Ledger.

Brandon BioCatalyst

Dr Andrew Nash

Coverage

Stories naming Dr Andrew Nash. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Fund close $439m

Peter Beattie AC appointed Brandon BioCatalyst Chair

Brandon BioCatalyst has named Peter Beattie its chair as Bill Ferris retires, with Andrew Nash joining the board and Ross King becoming deputy; manager Brandon Capital's newly raised $439 million fund was noted.

Series A $14m

$14m invested in University of Melbourne spin-out to create vaccine for periodontal gum disease

A biotech spin-out from the University of Melbourne has raised a Series A to develop a gum disease vaccine, backed by a biomedical translation fund, a large biotech company and the university itself.

Also Brandon BioCatalyst portfolio·Startup Daily·denteric.com·denteric.com·@AuManufacturing·Startup Daily

Something wrong? Tell us